Hap Trading, LLC Gilead Sciences, Inc. Call Options Transaction History

Hap Trading, LLC

  • $872 Billion
  • Q3 2024

Call Options

25 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$73.94 - $80.67 $391,882 - $427,551
-5,300 Reduced 27.46%
14,000 $1.05 Million
Q2 2023

Aug 11, 2023
SELL
$76.01 - $86.7 $1.22 Million - $1.4 Million
-16,100 Reduced 45.48%
19,300 $1.49 Million
Q1 2023

May 12, 2023
BUY
$77.31 - $88.08 $1.29 Million - $1.47 Million
16,700 Added 89.3%
35,400 $135,000
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $5.78 Million - $8.3 Million
-92,800 Reduced 83.23%
18,700 $135,000
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $9.92 Million - $11.3 Million
-166,600 Reduced 59.91%
111,500 $406,000
Q2 2022

Aug 12, 2022
BUY
$57.72 - $65.01 $1.06 Million - $1.19 Million
18,300 Added 7.04%
278,100 $1.01 Million
Q1 2022

May 12, 2022
BUY
$57.92 - $72.58 $8.1 Million - $10.1 Million
139,800 Added 116.5%
259,800 $802,000
Q4 2021

Feb 14, 2022
SELL
$64.88 - $73.64 $1.15 Million - $1.31 Million
-17,800 Reduced 12.92%
120,000 $623,000
Q3 2021

Nov 10, 2021
BUY
$67.69 - $73.03 $3.43 Million - $3.7 Million
50,700 Added 58.21%
137,800 $607,000
Q2 2021

Aug 11, 2021
BUY
$63.47 - $69.35 $2.16 Million - $2.36 Million
34,100 Added 64.34%
87,100 $328,000
Q1 2021

May 14, 2021
SELL
$60.0 - $68.46 $3.59 Million - $4.1 Million
-59,900 Reduced 53.06%
53,000 $173,000
Q4 2020

Feb 16, 2021
BUY
$56.65 - $64.55 $2.5 Million - $2.85 Million
44,200 Added 64.34%
112,900 $103,000
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $757,620 - $952,576
-12,200 Reduced 15.08%
68,700 $90,000
Q2 2020

Aug 10, 2020
SELL
$72.34 - $84.0 $8.88 Million - $10.3 Million
-122,700 Reduced 60.27%
80,900 $348,000
Q1 2020

May 08, 2020
BUY
$62.63 - $80.22 $10.9 Million - $14 Million
174,300 Added 594.88%
203,600 $995,000
Q4 2019

Feb 11, 2020
SELL
$61.62 - $67.78 $123,240 - $135,560
-2,000 Reduced 6.39%
29,300 $83,000
Q3 2019

Nov 12, 2019
BUY
$62.51 - $69.0 $262,542 - $289,800
4,200 Added 15.5%
31,300 $69,000
Q2 2019

Aug 14, 2019
BUY
$61.87 - $69.38 $216,545 - $242,829
3,500 Added 14.83%
27,100 $83,000
Q1 2019

May 10, 2019
SELL
$62.53 - $70.05 $6.13 Million - $6.87 Million
-98,100 Reduced 80.61%
23,600 $64,000
Q4 2018

Feb 12, 2019
SELL
$60.54 - $79.0 $27.3 Million - $35.6 Million
-450,800 Reduced 78.74%
121,700 $22,000
Q3 2018

Nov 09, 2018
BUY
$71.28 - $78.92 $31.8 Million - $35.2 Million
446,000 Added 352.57%
572,500 $407,000
Q2 2018

Aug 13, 2018
BUY
$64.88 - $75.68 $142,736 - $166,496
2,200 Added 1.77%
126,500 $255,000
Q1 2018

May 11, 2018
BUY
$72.84 - $88.8 $4.95 Million - $6.03 Million
67,900 Added 120.39%
124,300 $576,000
Q4 2017

Feb 09, 2018
SELL
$71.15 - $83.52 $234,795 - $275,616
-3,300 Reduced 5.53%
56,400 $18,000
Q3 2017

Nov 08, 2017
BUY
$72.11 - $85.47 $4.3 Million - $5.1 Million
59,700
59,700 $245,000

Others Institutions Holding GILD

# of Institutions
1,931
Shares Held
991M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email